Huajian Healthcare (01931): Building a “Global Enhanced Ethereum (ETH) Treasury”, upgrading the company's global strategy, and creating value for ecosystem participants

Zhitong Finance App News, Huajian Healthcare (01931) issued an announcement. The Group's latest strategic upgrade and upgrade measures - passed by the board of directors resolution, the group officially launched the “Global Enhanced Ethereum (ETH) Treasury Strategy with a Downside Protection Mechanism” strategy (Ethereum (ETH) Treasury Strategy), and disclosed relevant business logic, implementation paths, differentiated downward protection mechanisms and enhanced strategies and future vision.

The Board of Directors hereby announces that the “NewCo+RWA” Web3 Exchange has been officially named “ivd.xyz” (ivd.xyz Exchange), and the “NewCo+RWA” Web3 exchange ecosystem that the company is committed to building, which focuses on the high-tech assets of global medical innovative drugs, is the “ivd.xyz exchange ecosystem”.

Global upgrade

In order to match the Group's medical innovative drug asset tokenization (RWA) and the large-scale commercial application of IVDD stablecoins within the IVD.xyz exchange ecosystem, all of the Group's RWA issuance, trading, settlement and ecological governance are deeply coupled to the Ethereum (Ethereum) ecosystem. Therefore, Ethereum (ETH) is both an underlying fuel and a core reserve asset, and there is a continuous and large-scale rigid demand for Ethereum (ETH).

On the premise of complying with applicable laws and regulations and the Hong Kong Stock Exchange Limited securities listing rules, the company believes that further upgrading the original decentralized asset allocation and innovative drug RWA strategy, using Ethereum (ETH) as the core hub to create a global enhanced Ethereum (ETH) vault with multiple downside protection mechanisms, can maximize the amount of Ethereum (ETH) per share of the company's shares, reduce systemic risks, and lead traditional medical industry capital to efficiently cross into a new financial paradigm on the Web3 chain.

The asset logic of a listed company strategically allocating ETH

Based on strategic layout requirements, the Group uses Ethereum (ETH) as a core reserve asset, which not only meets the technical requirements of medical innovative drug asset tokenization (RWA), but also conforms to the global institutional investors' allocation trend of crypto assets. As a smart contract platform, Ethereum (ETH)'s ecological maturity and liquidity advantages provide the underlying support for the group to build a “Web3 value bridge with zero cognitive threshold”.

The purpose of this strategic upgrade is not only to meet application needs in line with the Ethereum ecosystem, but also to systematically improve the efficiency of medical innovative drug research and development, and use an integrated on-chain capital and asset allocation model to push capital flow efficiency, asset turnover efficiency, and risk hedging efficiency to an unprecedented level in the medical innovation industry.

Trend Preview: Global Consensus and Ecological Value of Ethereum (ETH)

Currently, Ethereum (ETH) is not only the core carrier for Web3 applications such as DeFi and NFT, but has also become a key target for traditional financial institutions to lay out the crypto circuit. Hong Kong's second virtual asset policy declaration clearly states that tokenizing real-world assets and financial market instruments can enhance the efficiency, accessibility and potential liquidity of the Hong Kong market. Through the HKMA's Ensemble project, Hong Kong actively encourages innovative application scenarios, including tokenizing traditional financial products and revenue streams from real-world assets. Meanwhile, the US “Clarity Act” defines mature blockchain system assets as commodities, which are regulated by the CFTC. In this context, the Group is building a “global enhanced Ethereum (ETH) vault”, which is not only an accurate response to the global regulatory framework, but also a strategic first step to seize financial infrastructure dividends on the Web 3.0 chain.

The Group's Ethereum (ETH) Treasury Strategy continues to expand the size of Ethereum (ETH) reserves through the “Ethereum (ETH) Reserve Bank” and “Ethereum (ETH) Creation Engine” dual-track strategy. Under the premise of complying with applicable laws, regulations and listing rules, the goal is to become the world's largest listed Ethereum (ETH) reserve fund.

In order to protect the interests of shareholders, RWA holders and potential investors, the Board of Directors has authorized management to establish the following seven-tier “verifiable, enforceable, and quantifiable” mechanism under the premise of complying with applicable laws and regulations and listing rules: 1. ATM (At-The-Market) mechanism; 2. Priority inferior hierarchical structure; 3. RWA price repurchase commitment; 4. Clinical VC underwriting mechanism; 5. Ethereum (ETH) derivatives hedging; 6. Fixed investment strategy; 7. Share repurchase plan.

In order for the “global enhanced Ethereum (ETH) treasury with a downside protection mechanism” to continue to lead in terms of reserve size, revenue intensity, and capital efficiency, the company's board of directors has authorized the management to build a separate “three-tier enhanced engine” on the premise of complying with applicable laws, regulations and listing rules in addition to the original seven-fold downside protection. The engine uses a positive cycle of “pledge-financing-re-pledge”, superimposes a “interest-option” two-round income amplifier, and introduces top quantitative management genes in the “merger and acquisition+entrustment” method to achieve the qualitative transformation of Ethereum (ETH) assets from “passive coin hoarding” to “active generation, reinvestment, and re-expansion”.

In the process of advancing the “Global Enhanced Ethereum (ETH) Treasury” strategy, the Group has systematically sorted out and focused on pioneering practices in the field of global cryptocurrency asset reserves, paying particular attention to the models of companies such as US listed company MicroStrategy (MicroStrategy), Bitmine Immersion Tech, SharpLink Gaming, Japanese stock listed company Metaplanet, and Hong Kong stock listed company Liberal Arts Interactive. These prior practices are the Group The development of the “Global Enhanced Ethereum (ETH) Treasury” strategy provides an important market-based reference.

At the same time, the evolution path of the Ethereum community and its technology ecosystem, in particular the technical ideas proposed by Ethereum founder Vitalik Buterin (God V), and the contributions of Dr. Xiao Feng, an important supporter of Ethereum, in ecological construction, provided a key reference for the group to understand the underlying logic of blockchain technology and the rules of ecological development. In addition, the practices of institutions such as HashKey Group in the compliance process have also provided the Group with experience that can be learned from in building a compliance framework.

Furthermore, the design of the Group's strategic model fully takes into account the mature practices of the above entities in managing cryptographic assets such as Ethereum (ETH), building a technological ecosystem, and compliant operation, and adaptively innovates in line with the special characteristics of the medical innovative pharmaceutical industry. Based on medical innovation expertise and financial innovation practices, Huajian Medical will systematically improve the efficiency of medical innovative drug research and development and capital allocation, and jointly write a new chapter of value in the era of on-chain finance.